Hepatyrix

Hepatyrix is a combined Hepatitis A and Typhoid vaccination. A combination of inactivated Hepatitis A virus and Vi polysaccharide of Salmonella typhi bacteria manufactured by GlaxoSmithKline

References

External links

GlaxoSmithKline

Subsidiaries

GlaxoSmithKline Pakistan
GlaxoSmithKline Pharmaceuticals Ltd
Stiefel Laboratories
ViiV Healthcare (85%)

Predecessors,
acquisitions

Allen & Hanburys
Beecham Group
Block Drug
Burroughs Wellcome
Glaxo
Glaxo Wellcome
Human Genome Sciences
Recherche et Industrie Thérapeutiques
Reliant Pharmaceuticals
S. E. Massengill Company
SmithKline Beecham
Smith, Kline & French

Products

Current

Pharmaceuticals	Advair Alli Augmentin Avandia Beconase Boniva Flixonase Hycamtin Lamictal Paxil/Seroxat Serlipet Tagamet Ventolin Wellbutrin/Zyban Zantac … more

Vaccines	Hepatyrix Pandemrix Twinrix

Other	Aquafresh Horlicks Nicoderm Nicorette NiQuitin Sensodyne Tums … more

Former

BC Powder
Geritol
Goody's Powder
Lucozade
Ribena

People

Governance	Chris Gent (chair) Andrew Witty (CEO)

Other	Thomas Beecham Silas M. Burroughs Mahlon Kline John K. Smith Henry Wellcome

Litigation

Canada v. GlaxoSmithKline Inc.
Christopher v. SmithKline Beecham Corp.
GlaxoSmithKline Services Unlimited v Commission
United States v. Glaxo Group Ltd.
United States v. GlaxoSmithKline

Other

Drug Industry Document Archive
GlaxoSmithKline Prize
Side Effects
Study 329

Category

This article is issued from Wikipedia - version of the Sunday, August 11, 2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.